Inotiv (NOTV) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
11 May, 2026Executive summary
Revenue for the quarter ended March 31, 2026, was $117.7M, down 5.4% year-over-year, driven by a 10.7% decline in RMS revenue, partially offset by a 3.9% increase in DSA revenue.
Net loss for the quarter was $32.5M (27.6% of revenue), compared to $14.9M (12.0%) in the prior year quarter.
For the six months ended March 31, 2026, revenue was $238.5M (down 2.3% year-over-year), with a net loss of $60.8M (25.5% of revenue), compared to $42.5M (17.4%) in the prior year period.
DSA backlog increased to $151.8M at March 31, 2026, from $138.2M at September 30, 2025.
Financial highlights
DSA segment revenue rose 3.9% to $47.1M for the quarter, with operating income of $1.0M (up from a $0.1M loss), driven by increased safety assessment and analytical services.
RMS segment revenue fell 10.7% to $70.6M, with an operating loss of $1.9M (down from $11.4M income), mainly due to lower NHP volumes and higher operating expenses.
Consolidated gross margin declined due to higher costs and lower RMS revenue.
Interest expense increased, contributing to higher net losses.
Outlook and guidance
Management forecasts noncompliance with financial covenants for the remainder of fiscal 2026 and substantial doubt exists about the ability to continue as a going concern.
The company is exploring recapitalization, refinancing, restructuring, or other strategic alternatives.
Ongoing efforts to optimize capital allocation, reduce expenses, and improve operating results are underway.
Latest events from Inotiv
- Q1 2026 revenue hit $120.9M as efficiency, site optimization, and compliance drive growth.NOTV
Investor presentation9 Feb 2026 - Revenue up 0.8% with DSA growth, but net loss and liquidity risks persist.NOTV
Q1 20269 Feb 2026 - Q3 revenue fell 32.8% with a $26.1M loss; legal issues resolved but liquidity risks remain.NOTV
Q3 20242 Feb 2026 - New services and capacity drive DSA growth, while NHP and small animal markets adjust to shifting demand.NOTV
Jefferies Global Healthcare Conference1 Feb 2026 - FY 2024 revenue fell 14.3% with margin pressure, but operational changes target recovery in 2025.NOTV
Q4 202412 Jan 2026 - Operational optimization and DSA growth drive revenue and margin expansion.NOTV
H.C. Wainwright 27th Annual Global Investment Conference27 Dec 2025 - Registering $350M in securities, including $50M at-the-market shares, amid going concern risk.NOTV
Registration Filing16 Dec 2025 - Resale registration covers 4.1M shares from warrants; up to $6.5M may be raised if exercised for cash.NOTV
Registration Filing16 Dec 2025 - Strong DSA growth and cost savings drove improved results despite a Q4 cyber incident.NOTV
Q4 20254 Dec 2025